Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

25/03/2024 09:00

Mar 25 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 29, 2024        Feb 28, 2023     May 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               40.67               38.73            54.09    
                   (+5.0 pct)          (+0.4 pct)       (+4.0 pct)  
  Operating          863 mln             896 mln            1.06    
                   (-3.7 pct)          (-10.4 pct)      (-26.5 pct) 
  Recurring          799 mln             890 mln          978 mln   
                   (-10.2 pct)         (-12.2 pct)      (-31.6 pct) 
  Net                177 mln             208 mln          168 mln   
                   (-15.2 pct)         (-35.2 pct)      (-49.4 pct) 
  EPS               17.22 yen           22.24 yen        16.01 yen  
  EPS Diluted       16.48 yen           16.89 yen                   
  Ann Div                               14.00 yen        20.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        20.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T